1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6C397C3753EAFAE91002587730027E091
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/insights/new-report-tackles-how-pharma-is-using-social-media-for-hcp-education?opendocument
18
19opendocument
203.89.204.127
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25Main






New Report Tackles How Pharma is Using Social Media for HCP Education

CHAPEL HILL, N.C., Oct. 11, 2021/PRNewswire/ -- The pandemic had an immediate impact on pharmaceutical medical education programs, with organizations quickly pivoting from live meetings to virtual meetings and other multichannel approaches to delivering medical education.

This new Best Practices, LLC study highlights current trends and future directions for how pharma is utilizing social platforms, patient education activities and sponsorships/corporate memberships in a world still dealing with COVID.

The study showed that social media is an up-and-coming tool for pharma medical education; a third of participants (34%) already use public social media platforms for HCP accredited medical education, and another 22% said they will by the end of 2022. Meanwhile, 44% don’t use social media for HCP education.

The research study will enable you to see how your company’s approach compares with industry peers on key issues affecting medical education, in particular social media, IME grant program structure and parameters, patient education and sponsorships/corporate memberships.

Download the white paper, "Medical Education Excellence: Current Trends and Future Directions for Utilizing Social Platforms, Patient Groups and Sponsorships" is a new 76-page study that examines how pharma is adjusting its medical education programs for the future.

Topics addressed in this research include:

  • Utilization and Effectiveness of Public and Closed Social Media Platforms
  • IME Grant Support for Patient Medical Education Activities
  • Medical Sponsorships/Corporate Memberships Management
  • Utilization and Effectiveness of Virtual Formats for Medical Education
This study engaged 32 leaders from 27 biopharmaceutical companies via a benchmark survey with deep-dive interviews conducted with selected participants to provide further insight. Data segmented by respondent’s geographical responsibility – US vs. Global + US vs. Global ex-US.

To learn more about our Medical Education report, download a complimentary report excerpt at https://www.best-in-class.com/rw82.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.